Congressional action BIO wants to see in 2024
As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year. BIO’s …
As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year. BIO’s …
The World Health Organization (WHO) has issued a warning for urgent measures amid an “alarming rise” in measles outbreaks in Europe last year. The …
‘Alarming rise’ of measles outbreaks in Europe, WHO warns Read More »
Vaccines have changed the course of human history as we know it. Since the first vaccine was discovered in the late 1700s, vaccine technology …
What does the vaccine pipeline look like – and how can we strengthen it? Read More »
The World Economic Forum (WEF) wrapped up its annual meeting in Davos last week, with global government and business leaders discussing the most pressing …
Davos 2024: key takeaways on food, climate, and health Read More »
Four years after the start of the pandemic, it is well known that COVID-19 is linked with thrombosis. A new report from the Centers …
CDC report: up-to-date COVID-19 vaccinations can protect against severe outcomes Read More »
Biotechnology can play a key role in improving human health and a better environment, help us curb food insecurity, and strengthening energy security while …
We’re on the brink of a biotech ‘revolution,’ says NSCEB report Read More »
Recently, it’s seemed like everyone has been sick this winter—an observation that is not too far off. This year’s COVID surge is the second-highest …
RSV recap: what to know about immunizations and safety in 2024 Read More »
J.P. Morgan’s massive Healthcare Conference wrapped last week. BIO was busy as ever in San Francisco, connecting companies with potential partners, discussing innovation, and …
2024 JPM Healthcare Conference: top 5 BIO takeaways Read More »
After two decades of research and development, Sutro Biopharma is still a few years away from seeking market approval for its first drug, a …
Loss of tax incentive for R&D threatens biotech innovation Read More »
Brad Bailey is Senior Vice President and U.S. General Manager for Genmab, a global biotechnology company at the forefront of discovering, developing, and delivering …